Circulating tumor cells and FDG-PET/CT: biological and functional methods for therapeutic monitoring in metastatic breast

被引：0
|
作者：
Cristofanilli, M.
De Giorgi, U.
Rohren, E.
Ueno, N. T.
Miller, C.
Doyle, G., V
Jackson, S.
Andreopoulou, E.
Handy, B. C.
Hortobagyi, G. N.
Macapinlac, H. A.
Fritsche, H. A.
Valero, V.
机构：
[1] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Immunicon Corp, Huntingdon Valley, PA USA
来源：
CANCER RESEARCH | 2009年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：362S / 362S
页数：1
相关论文
共 50 条
  • [1] Circulating Tumor Cells and FDG-PET/CT for the Therapeutic Monitoring of Bone Metastases from Breast Cancer
    De Giorgi, U.
    Mego, M.
    Rohren, E.
    Valero, V.
    Handy, B. C.
    Jackson, S.
    Reuben, J. M.
    Macapinlac, H. A.
    Cristofanilli, M.
    Ueno, N. T.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 573S - 573S
  • [2] Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer
    De Giorgi, U.
    Valero, V.
    Rohren, E.
    Mego, M.
    Doyle, G. V.
    Miller, M. C.
    Ueno, N. T.
    Handy, B. C.
    Reuben, J. M.
    Macapinlac, H. A.
    Hortobagyi, G. N.
    Cristofanilli, M.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 (01) : 33 - 39
  • [3] CIRCULATING TUMOR CELLS AND BONE METASTASES AS DETECTED BY FDG-PET/CT IN PATIENTS WITH METASTATIC BREAST CANCER
    De Giorgi, U.
    Valero, V.
    Rohren, E.
    Doyle, G. V.
    Ueno, N. T.
    Handy, B. C.
    Reuben, J. M.
    Cristofanilli, M.
    Macapinlac, H. A.
    Hortobagyi, G. N.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 : 56 - 57
  • [4] Correlation among [18-F] FDG-PET/CT, tumor marker CA 27.29, and circulating tumor cells in metastatic breast cancer
    Saad, A. A.
    Rikhye, S.
    Kanate, A.
    Sehbai, A.
    Marano, G.
    Hobbs, G.
    Abraham, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] FDG-PET/CT findings of a metastatic pituitary tumor
    Ilkhchoui, Yashar
    Appelbaum, Daniel E.
    Pu, Yonglin
    [J]. CANCER IMAGING, 2010, 10 (01): : 114 - 116
  • [6] FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: Today, Tomorrow, and Beyond
    Hildebrandt, Malene Grubbe
    Lauridsen, Jeppe Faurholdt
    Vogsen, Marianne
    Holm, Jorun
    Vilstrup, Mie Holm
    Braad, Poul-Erik
    Gerke, Oke
    Thomassen, Mads
    Ewertz, Marianne
    Hoilund-Carlsen, Poul Flemming
    [J]. CANCERS, 2019, 11 (08)
  • [7] Response Monitoring of Metastatic Breast Cancer: A Retrospective Cohort Study Comparing CT and FDG-PET/CT
    Oltmann, Hjalte
    Alamdari, Tural
    Ljungstroem, Lasse
    Bulow, Jakob
    Vogsen, Marianne
    Gerke, Oke
    Hoilund-Carlsen, Poul Flemming
    Hildebrandt, Malene
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [8] Circulating tumor DNA for monitoring classic Hodgkin lymphoma patients: Correlation with FDG-PET/CT
    Fernandez, Sara
    Cereceda, Laura
    Diaz, Eva
    Figueroa, Sasha
    Reguera, Laura
    Menendez, Victoria
    Solorzano, Jose L.
    Montalban, Carlos
    Estevez, Monica
    Garcia, Juan F.
    [J]. EJHAEM, 2024, 5 (01): : 70 - 75
  • [9] FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: The Feasibility and Benefits of Applying PERCIST
    Vogsen, Marianne
    Bulow, Jakob Lykke
    Ljungstrom, Lasse
    Oltmann, Hjalte Rasmus
    Alamdari, Tural Asgharzadeh
    Naghavi-Behzad, Mohammad
    Braad, Poul-Erik
    Gerke, Oke
    Hildebrandt, Malene Grubbe
    [J]. DIAGNOSTICS, 2021, 11 (04)
  • [10] Clinical Impact of FDG-PET/CT Compared with CE-CT in Response Monitoring of Metastatic Breast Cancer
    Naghavi-Behzad, Mohammad
    Oltmann, Hjalte Rasmus
    Alamdari, Tural Asgharzadeh
    Bulow, Jakob Lykke
    Ljungstrom, Lasse
    Braad, Poul-Erik
    Asmussen, Jon Thor
    Vogsen, Marianne
    Kodahl, Annette Raskov
    Gerke, Oke
    Hildebrandt, Malene Grubbe
    [J]. CANCERS, 2021, 13 (16)
12345